Bill > HB1380

This bill establishes the Insulin Access and Affordability Program through the Oklahoma Health Care Authority to address rising insulin costs and improve patient access to affordable prescription drugs. The program aims to increase marketplace competition and reduce drug prices by empowering the Authority to collaborate with nonprofit pharmaceutical companies and organizations. Specifically, the Authority can enter into agreements to accelerate the development of fast-acting insulin and create partnerships that would make insulin available at reduced prices (no more than $30 per vial or $55 per pack of five pre-filled pens). The program will also track potential savings for Oklahoma residents and self-insured individuals, and require matching funds from nonprofit partners. The bill is set to become effective on July 1, 2025, with an emergency clause that allows immediate implementation upon passage, highlighting the urgent public health need to make insulin more affordable and accessible for Oklahoma residents.

Budget and Finance, Health and Social Services

http://www.oklegislature.gov/BillInfo.aspx?Bill=hb1380&Session=2600